A phase I trial of the oral hedgehog inhibitor taladegib (LY2940680) in combination with weekly paclitaxel in patients with advanced, solid tumours.Rosalind Glasspool, T.R. Jeffry Evans, Trevor Tucker et al.|Journal of Clinical Oncology|2017Cited by 3